<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04897048</url>
  </required_header>
  <id_info>
    <org_study_id>KEK-ZH-NR. 2012-0251_5</org_study_id>
    <nct_id>NCT04897048</nct_id>
  </id_info>
  <brief_title>Effect of Short-term Oxygen During CPET in ILD</brief_title>
  <official_title>Effect of Short-term Ambulatory Oxygen Therapy on Cardiopulmonary Exercise Capacity in Patients With Interstitial Lung Disease (ILD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In a randomized, sham-controlled crossover trial the investigators will test whether&#xD;
      supplemental oxygen given during cardiopulmonary exercise testing will improve exercise&#xD;
      performance and physiological parameters in patients with interstitial lung disease.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Work Rate (in watts)</measure>
    <time_frame>1 day</time_frame>
    <description>Maximal Work Rate (Watt max) measured during incremental exercise tests (IET) in cardiopulmonary exercise tests</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Endurance time (in seconds)</measure>
    <time_frame>1 day</time_frame>
    <description>Endurance (sec) with 75% Wmax measured during constant work rate exercise tests (CWRET) in cardiopulmonary exercise tests</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>changes in physiological vital signs: Heart rate (hr)</measure>
    <time_frame>1 day</time_frame>
    <description>Hr (in beats per minute)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>changes in physiological vital signs: Blood pressure</measure>
    <time_frame>1 day</time_frame>
    <description>Systolic and diastolic blood pressure (in mmHg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in breathing patterns: Minute ventilation (VE)</measure>
    <time_frame>1 day</time_frame>
    <description>VE (in liters per minute)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes breathing patterns: Tidal volume (Vt)</measure>
    <time_frame>1 day</time_frame>
    <description>Vt (in liters)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in breathing patterns: Oxygen uptake (VO2)</measure>
    <time_frame>1 day</time_frame>
    <description>VO2 (in liters per minute)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in breathing patterns: Carbon dioxide output (VCO2)</measure>
    <time_frame>1 day</time_frame>
    <description>VCO2 (in liters per minute)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in breathing patterns: Breathing equivalent for O2 (VE/VO2)</measure>
    <time_frame>1 day</time_frame>
    <description>ratio between minute ventilation and oxygen uptake</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in breathing patterns: Breathing equivalent for O2 (VE/VCO2)</measure>
    <time_frame>1 day</time_frame>
    <description>ratio between minute ventilation and carbon dioxide output</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in breathing patterns: VE/VCO2Slope</measure>
    <time_frame>1 day</time_frame>
    <description>Ratio between minute ventilation and carbon dioxide output if carbon dioxide reaches the breathing plateau</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in breathing patterns: Ventilatory threshold one (Vt1)</measure>
    <time_frame>1 day</time_frame>
    <description>represents the start of anaerobic metabolism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in breathing patterns: Ventilatory threshold two (Vt2)</measure>
    <time_frame>1 day</time_frame>
    <description>represents the start of higher percentage of the anaerobic metabolism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in arterial blood: arterial partial pressure of O2 (PaO2)</measure>
    <time_frame>1 day</time_frame>
    <description>PaO2 (in kPa)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in arterial blood: arterial partial pressure of CO2 (PaCO2)</measure>
    <time_frame>1 day</time_frame>
    <description>PaCO2 (in kPa)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in arterial blood: arterial lactate concentration</measure>
    <time_frame>1 day</time_frame>
    <description>lactate concentration (in mmol per liter)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in arterial blood: pondus Hydrogenii (pH) values</measure>
    <time_frame>1 day</time_frame>
    <description>pH (1-14)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in arterial blood: Bicarbonate (HCO3)</measure>
    <time_frame>1 day</time_frame>
    <description>HCO3 (in mmol per liter)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in tissue oxygenation: Pulse oxymetrie (SpO2, measured at the finger)</measure>
    <time_frame>1 day</time_frame>
    <description>SpO2 (in percent)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in tissue oxygenation: Cerebral tissue oxygenation (CTO, measured at the forehead)</measure>
    <time_frame>1 day</time_frame>
    <description>CTO (in percent)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in tissue oxygenation: Muscle tissue oxygenation (MTO, measured at the quadriceps muscle)</measure>
    <time_frame>1 day</time_frame>
    <description>MTO (in percent)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Interstitial Lung Disease</condition>
  <arm_group>
    <arm_group_label>Oxygen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Supplemental oxygen will be applied via a mask during CPET</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Air</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham ambient air will be applied via mask during CPET</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Incremental exercise test (IET)</intervention_name>
    <description>Incremental cardio pulmonary exercise test until exhaustion</description>
    <arm_group_label>Air</arm_group_label>
    <arm_group_label>Oxygen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Constant work rate exercise test (CWRET)</intervention_name>
    <description>constant (on 75% Wmax) cardio pulmonary exercise test until exhaustion</description>
    <arm_group_label>Air</arm_group_label>
    <arm_group_label>Oxygen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  interstitial lung disease, diagnosed by high-resolution CT&#xD;
&#xD;
          -  FEV1/FVC &gt;70% and FVC &lt;85% predicted&#xD;
&#xD;
          -  stable medication for at least 4 weeks&#xD;
&#xD;
          -  Desaturation in SpO2 in 6-minute walk test of ≥ 4% to absolute values ≤ 92%&#xD;
&#xD;
          -  Signed Informed Consent&#xD;
&#xD;
          -  Male and female patients 18 to 80 years of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe daytime hypoxemia (PaO2 ≤7.3 or &lt;55 mmHg at rest)&#xD;
&#xD;
          -  Other clinically significant concomitant disease states (e.g., cardiovascular disease,&#xD;
             hepatic dysfunction, etc)&#xD;
&#xD;
          -  Inability to follow the procedures of the study, e.g. due to language problems,&#xD;
             psychological disorders, dementia or confusional state of the subject, neurological or&#xD;
             orthopaedic problems with walking disability or inability to ride a bicycle&#xD;
&#xD;
          -  Women who are pregnant or breast feeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Silvia Ulrich, Prof. Dr.</last_name>
    <phone>+41442552220</phone>
    <email>silvia.ulrich@usz.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Respiratory Clinic, University Hospital of Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 9, 2021</study_first_submitted>
  <study_first_submitted_qc>May 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2021</study_first_posted>
  <last_update_submitted>May 17, 2021</last_update_submitted>
  <last_update_submitted_qc>May 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Interstitial</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

